Intas Pharmaceuticals Ltd Walk-In 6th August 2022 for Oral Solid Dosage/ablet Capsule Manufacturing - William naik

Mobile Menu

Top Ads

More News

logoblog

Intas Pharmaceuticals Ltd Walk-In 6th August 2022 for Oral Solid Dosage/ablet Capsule Manufacturing

22_08

 Intas Pharmaceuticals Ltd Walk In Interview 2022 B.Pharma in Any Specialization for Oral Solid Dosage / Tablet Capsule Manufacturing At Ahmedabad. Intas Pharmaceuticals Ltd Notification full details below.Interested and eligible candidates can attend interview on scheduled time and venue.Experience spanning three decades in healthcare, with a wide range of formulations to meet the needs of ailing humanity, Intas Pharmaceuticals headquartered at Ahmedabad (India), is now a force to reckon with, in the global pharma horizon.


Vacancy details:

  • Post Name: Oral Solid Dosage / Tablet Capsule Manufacturing
  • Qualification: B.Pharma in Any Specialization   
  • Experienced:02 to 5 years

Job Description: Intas Pharmaceuticals Ltd Hiring For Oral Solid Dosage / Tablet Capsule Manufacturing !

Important Details :

  • Location: Ahmedabad
  • Date:6th August 2022
  • Time: 9.30 AM – 1.00 PM
  • Venue:-Intas Pharmaceuticals Ltd., Matoda 457/458, Sarkhej – Bavla highway, Matoda, Taluka: Sanand, Ahmedabad- 382210
  • Post of date:04/08/2022
  • Selection Process: The selection will be on the basis of Interview.

Job description.

Roles and Responsibilities

Oral Solid Dosage / Tablet Capsule Manufacturing area.

Coating / Dispensing / Dispatch / Compression / Granulation

Desired Candidate Profile

Good Communication

Ready to work in shifts

About Company:

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world. It has been growing at about 25.5% CAGR over the last 5 years and crossed the $1.9 billion mark in the past financial year. The company has set up a network of subsidiaries, under the name Accord Healthcare in EU, US, Canada, SA, Australia, APAC as well as CIS & MENA regions. Intas is present in 85+ countries, with more than 69% of its revenue coming from global business.